Table 5. Association between ACYP2 haplotypes and the risk of liver cancer.

SNPs	Haplotype	Without adjustment			With adjustment
		OR	95% CI	P	OR	95% CI	P
rs1682111/ rs843752/ rs10439478/ rs843645/ rs11125529/ rs12615793/ rs843711/ rs11896604	ATATCGCC	0.78	0.64–0.94	0.010	0.76	0.62–0.92	0.006
	TTCTAATG	1.18	0.94–1.49	0.160	1.18	0.93–1.51	0.176
	TGAGCGTC	1.14	0.93–1.39	0.204	1.12	0.91–1.38	0.288
	TTCTCGCC	0.95	0.76–1.18	0.641	1.02	0.81–1.28	0.851
	TTCTCGTG	1.21	0.55–2.63	0.636	1.19	0.53–2.67	0.677
	TTCTCACC	0.9	0.43–1.88	0.789	0.81	0.38–1.72	0.587
rs843706/ rs17045754	AC	1.21	0.96–1.53	0.100	1.22	0.96–1.55	0.107
	AG	1.21	1.00–1.46	0.055	1.17	0.96–1.43	0.115
	CG	0.76	0.64–0.91	0.002	0.78	0.65–0.93	0.006

P-values were calculated using the Wald test.

P < 0.05 indicates statistical significance.